Overview

A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic Atrophy

Status:
Completed
Trial end date:
2019-06-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and performance profile of the suprachoroidal surgical approach and the Delivery System.
Phase:
Phase 2
Details
Lead Sponsor:
Janssen Research & Development, LLC